Augmedix Inc.

NASDAQ: AUGX · Real-Time Price · USD
2.35
0.00 (0.00%)
At close: Oct 01, 2024, 9:57 PM

Augmedix Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
46.34M 21.99M 41.59M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a 612K 207K
Other Long-Term Assets
930K 1.55M 1.73M
Receivables
8.57M 6.35M 7.18M
Inventory
n/a -1.95M -1.87M
Other Current Assets
2.03M 1.95M 460K
Total Current Assets
56.82M 28.34M 48.77M
Property-Plant & Equipment
8.96M 3.14M 982K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
9.89M 5.3M 2.92M
Total Assets
66.71M 33.64M 51.68M
Account Payables
721K 1.56M 1.36M
Deferred Revenue
8.96M 7.25M 6.24M
Short-Term Debt
6.49M 4.62M 1.5M
Other Current Liabilities
3.22M 3.27M 3.45M
Total Current Liabilities
23.62M 8.82M 7.6M
Long-Term Debt
15.3M 11.38M 13.34M
Other Long-Term Liabilities
421K 509K 668K
Total Long-Term Liabilities
19.77M 23.36M 20.4M
Total Liabilities
43.39M 32.17M 28M
Total Debt
25.85M 19.76M 14.84M
Common Stock
5K 4K 4K
Retained Earnings
-144.96M -125.79M -101.73M
Comprehensive Income
-919K -440K -70K
Shareholders Equity
23.32M 1.47M 23.68M
Total Investments
n/a 612K 207K